Forte Steve 4
4 · Repare Therapeutics Inc. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Forte Steve
EVP, CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Shares
2025-03-04+14,000→ 61,670 total - Award
Employee Stock Option (right to buy)
2025-03-04+200,000→ 200,000 totalExercise: $1.17Exp: 2035-03-03→ Common Shares (200,000 underlying) - Award
Employee Stock Option (right to buy)
2025-03-04+85,000→ 85,000 totalExercise: $1.17Exp: 2035-03-03→ Common Shares (85,000 underlying)
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of March 4, 2026, March 4, 2027 and March 4, 2028, subject to Reporting Person continuing to provide service through each such date.
- [F2]Includes 895 and 2,000 shares acquired on August 15, 2024 and February 15, 2025, respectively, under the Issuer's employee stock purchase plan.
- [F3]The option will vest in in full on March 4, 2026, subject to Reporting Person continuing to provide service through such date.
- [F4]Twenty-five percent (25%) of the shares subject to the option shall vest on March 4, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.